• 1. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Introduction to (1-Methyl-1H-indazol-5-YL)methanol (CAS No. 1092961-11-9)

(1-Methyl-1H-indazol-5-YL)methanol, with the CAS number 1092961-11-9, is a significant compound in the realm of pharmaceutical and chemical research. This heterocyclic alcohol has garnered attention due to its unique structural properties and potential applications in drug development. The compound belongs to the indazole family, which is well-known for its role in various biological and pharmacological processes.

The molecular structure of (1-Methyl-1H-indazol-5-YL)methanol consists of a benzene ring fused with a pyrrole ring, featuring a methyl group at the 1-position and a hydroxymethyl group at the 5-position of the indazole core. This specific arrangement imparts distinct chemical reactivity, making it a valuable intermediate in synthetic chemistry. The presence of both electron-donating and electron-withdrawing groups enhances its versatility in forming various chemical bonds and interactions.

In recent years, there has been a surge in research focusing on indazole derivatives due to their potential as bioactive molecules. Studies have highlighted the importance of (1-Methyl-1H-indazol-5-YL)methanol in developing novel therapeutic agents. Its ability to act as a precursor for more complex molecules has made it a cornerstone in medicinal chemistry. Researchers have explored its applications in synthesizing compounds that target specific biological pathways, particularly those involved in inflammation, cancer, and neurological disorders.

One of the most compelling aspects of (1-Methyl-1H-indazol-5-YL)methanol is its role in the development of small-molecule inhibitors. These inhibitors are designed to interact with enzymes and receptors, modulating their activity to achieve therapeutic effects. For instance, studies have demonstrated its utility in creating inhibitors that target kinases, which are often overactive in cancer cells. By binding to these kinases, the inhibitors can disrupt signaling pathways that promote cell proliferation and survival.

The synthesis of (1-Methyl-1H-indazol-5-YL)methanol involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to optimize yield and purity. Techniques such as palladium-catalyzed cross-coupling reactions and nucleophilic substitutions have been particularly effective in constructing the indazole core structure. These methods not only enhance efficiency but also minimize byproduct formation, ensuring a higher quality final product.

The pharmacological properties of (1-Methyl-1H-indazol-5-YL)methanol have been extensively studied in preclinical models. Initial findings suggest that it exhibits moderate solubility in water, which is advantageous for formulation into oral or injectable drugs. Additionally, its stability under various conditions makes it suitable for long-term storage and transportation without significant degradation.

In the context of drug discovery, (1-Methyl-1H-indazol-5-YL)methanol serves as a versatile building block for more complex scaffolds. Researchers have leveraged its structure to develop analogs with enhanced pharmacokinetic profiles or improved target specificity. This flexibility underscores its importance as a key intermediate in pharmaceutical research.

The industrial application of (1-Methyl-1H-indazol-5-YL)methanol is also noteworthy. Its synthesis has been scaled up for commercial production, meeting the demands of academic and industrial research labs alike. The compound's availability ensures that researchers can explore its full potential without significant hurdles related to sourcing raw materials.

Looking ahead, the future prospects for (1-Methyl-1H-indazol-5-YL)methanol appear promising. Ongoing studies aim to uncover new therapeutic applications and optimize synthetic routes for greater efficiency. Collaborative efforts between academia and industry are expected to drive innovation, leading to the development of novel drugs based on this versatile compound.

In summary, (1-Methyl-1H-indazol-5-YL)methanol (CAS No. 1092961-11-9) is a pivotal compound in pharmaceutical research due to its unique structural features and broad applicability. Its role as an intermediate in drug synthesis, along with its potential bioactivity, positions it as a valuable asset in the quest for new therapeutic agents.

• 1071433-06-1(2-methyl-2H-indazole-4-carboxylic acid)
• 1092961-08-4((1-Methyl-1H-indazol-7-YL)methanol)
• 1092961-10-8((1-Methyl-1H-indazol-6-YL)methanol)
• 1159511-52-0((2-methyl-2H-indazol-5-yl)methanol)
• 1071433-05-0(1-Methyl-1H-indazole-4-carboxylic acid)
• 872607-89-1(1-Methyl-1H-indazole-5-carbaldehyde)
• 1031417-46-5(2-Methyl-2H-indazole-6-carboxylic acid)
• 1092961-12-0((1-Methyl-1H-indazol-4-YL)methanol)
• 1031417-77-2(1-Methyl-1H-indazole-6-carboxylic acid)
• 1176754-31-6(1-Methyl-1H-indazole-5-carboxylic acid)